PeterMartinDibattisteMD

PubMed

• Exploring the potential cost-effectiveness of a novel platelet assay for guiding dual antiplatelet therapy duration in acute coronary syndrome patients following percu...
  Katherine A Vilain, Peter M DiBattiste, David J Schneider, David J Cohen> ;Coronary Artery Disease. 2023 Jan 1
• 6 citations
  Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases.
  Lu Wang, Joel N. Swerdel, James Weaver, Brendan M. Weiss, Guohua Pan, Zhong Yuan, Peter M DiBattiste> ;Current Medical Research and Opinion. 2021 Apr 8
• 3 citations
  Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.
  Daniel L. Edmonston, Matthew T. Roe, Geoffrey A. Block, Paul T. Conway, Laura M. Dember, Peter M DiBattiste, Tom Greene, Ali Hariri, Lesley A. Inker, Tamara Isakova, M...> ;American Journal of Kidney Diseases. 2020 Dec 1
• 3 citations
  Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis
  Jeffrey I. Weitz, Annelise Segers, Gary E. Raskob, Robin S. Roberts, Charles W. Francis, Michael R. Lassen, Takeshi Fuji, Renée M Swaim, Lee Michael, Gary Peters, Pete...> ;Journal of Thrombosis and Haemostasis. 2019 Dec 1
• 8 citations
  Stroke prevention in atrial fibrillation: Closing the gap.
  Sean D. Pokorney, Bernard J. Gersh, Azhar Ahmad, Sana M. Al-Khatib, Melanie Blank, Megan Coylewright, Peter M DiBattiste, Jeff S. Healey, Olaf Hedrich, Elaine M. Hylek...> ;American Heart Journal. 2019 Apr 1
• 26 citations
  Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
  Bennett Levitan, Zhong Yuan, Alexander G.G. Turpie, Richard J. Friedman, Martin Homering, Jesse A. Berlin, Scott D. Berkowitz, Rachel B. Weinstein, Peter M DiBattiste> ;Vascular Health and Risk Management. 2014 Mar 26
• 18 citations
  Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions
  Troy C. Sarich, Gary Peters, Scott D. Berkowitz, Frank Misselwitz, Christopher C. Nessel, Paul Burton, Nancy Cook-Bruns, Anthonie W. A. Lensing, Lloyd Haskell, Elisabe...> ;Annals of the New York Academy of Sciences. 2013 Jul 1
• 17 citations
  Effects on platelet function of a direct acting antagonist of coagulation factor Xa
  Sukit M. Ringwala, Peter M DiBattiste, David J. Schneider> ;Journal of Thrombosis and Thrombolysis. 2012 Apr 12
• 18 citations
  Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
  Peter R. Kowey, Ramagopal Mudumbi, Joseph W. Aquilina, Peter M. DiBattiste> ;Drugs in R&D. 2011 Jan 1
• 5 citations
  A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo
  Christopher P. Cannon, Cong Chen, Sean P. Curtis, John Viscusi, Tuli Ahmed, Peter M. DiBattiste> ;Archives of Drug Information. 2008 Jul 1
• 21 citations
  Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
  Aaron D. Kugelmass, Sadanandan S, Nasser Lakkis, Peter M. DiBattiste, Robertson Dh, Laura A. Demopoulos, Gibson Cm, William S. Weintraub, Sabina A. Murphy, Christopher...> ;Critical Pathways in Cardiology. 2006 Sep 1
• 17 citations
  The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
  Jack L. Martin, Gang Jia, Seth S. Martin, Timothy Shapiro, Howard C. Herrmann, Peter M. DiBattiste, Eric J. Topol, David J. Moliterno> ;Catheterization and Cardiovascular Interventions. 2006 Apr 1
• 8 citations
  Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18.
  Benjamin A. Steinberg, Alexandria J. M. Braganza, Gemma Eminowicz, Peter M. DiBattiste, Gregory C. Flaker, Sabina A. Murphy, Christopher P. Cannon> ;Critical Pathways in Cardiology. 2005 Dec 1
• 8 citations
  Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial
  E. Magnus Ohman, Frans Van de Werf, Elliott M. Antman, Robert M. Califf, James A. de Lemos, C. Michael Gibson, Renee L. Oliverio, Lynn Harrelson, Carolyn H. McCabe, Pe...> ;American Heart Journal. 2005 Jul 1
• 38 citations
  The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy O...
  Peter B. Berger, Patricia J.M. Best, Eric J. Topol, Jennifer A. White, Peter M. DiBattiste, Albert W. Chan, Steen Dalby Kristensen, Howard C. Herrmann, David J. Moliterno> ;American Heart Journal. 2005 May 1
• 44 citations
  Correlation between the TIMI risk score and high-risk angiographic findings in non–ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhib...
  Jessica L. Mega, David A. Morrow, Marc S. Sabatine, Xue Qiao Zhao, Steven M. Snapinn, Peter M. DiBattiste, C. Michael Gibson, Elliott M. Antman, Eugene Braunwald, Pier...> ;American Heart Journal. 2005 May 1
• 25 citations
  Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRIS...
  Thao Huynh, Nicolo Piazza, Peter M. DiBattiste, Steven M. Snapinn, Ying Wan, Chantal Pharand, Pierre Théroux> ;International Journal of Cardiology. 2005 Apr 8
• 98 citations
  Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: A TACTICS-TIMI-18 substudy
  Hisham Dokainish, Manu Pillai, Sabina A. Murphy, Peter M. DiBattiste, Marc J. Schweiger, Amir Lotfi, David A. Morrow, Christopher P. Cannon, Eugene Braunwald, Nasser L...> ;Journal of the American College of Cardiology. 2005 Jan 4
• 4 citations
  Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction.
  Juhana Karha, C. Michael Gibson, Sabina A. Murphy, Peter M. DiBattiste, Christopher P. Cannon> ;The American Journal of Cardiology. 2004 Dec 15
• 42 citations
  A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non–ST-segment eleva...
  Saihari Sadanandan, Christopher P. Cannon, C. Michael Gibson, Sabina A. Murphy, Peter M. DiBattiste, Eugene Braunwald> ;Journal of the American College of Cardiology. 2004 Aug 18
• 15 citations
  Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).
  C. Michael Gibson, Kanwar P. Singh, Sabina A. Murphy, Peter M. DiBattiste, Laura A. Demopoulos, Christopher P. Cannon, Eugene Braunwald> ;The American Journal of Cardiology. 2004 Aug 15
• 100 citations
  Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarc...
  Saihari Sadanandan, Christopher P. Cannon, Kasi Chekuri, Sabina A. Murphy, Peter M. DiBattiste, David A. Morrow, James A. de Lemos, Eugene Braunwald, C. Michael Gibson> ;Journal of the American College of Cardiology. 2004 Aug 4
• 261 citations
  The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes
  Richard G. Bach, Christopher P. Cannon, William S. Weintraub, Peter M. DiBattiste, Laura A. Demopoulos, H. Vernon Anderson, Paul DeLucca, Elizabeth M. Mahoney, Sabina ...> ;Annals of Internal Medicine. 2004 Aug 3
• 2 citations
  Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregome...
  Deepak R. Talreja, Dieter Lubbe, James L. Orford, Ryan J. Lennon, Peter M. DiBattiste, Peter B. Berger> ;Journal of Thrombosis and Thrombolysis. 2004 Aug 1
• 167 citations
  Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a ran...
  Michael A. Blazing, James A. de Lemos, Harvey D. White, Keith A.A. Fox, Freek W.A. Verheugt, Diego Ardissino, Peter M. DiBattiste, Joanne Palmisano, David W. Bilheimer...> ;JAMA. 2004 Jul 7
• Join now to see all